Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Tactile Systems TechnologyTCMD 74 EV-to-EBIT is 16.11 as of Jul. 22, 2026, which is 25% below its 10-year median of 21.41. GuruFocus rates TCMD with a GF Score™ of 74/100 and a GF Value™ of $18.80 (Significantly Overvalued). The stock has 3 warning signs investors should review. Among 465 Medical Devices & Instruments companies, Tactile Systems Technology ranks better than 57.85% on this metric.
Tactile Systems Technology (NAS:TCMD) EV-to-EBIT Explanation
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Tactile Systems Technology's Enterprise Value for the quarter that ended in Mar. 2026 was $518.4 Mil.
Tactile Systems Technology's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $35.2 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Tactile Systems Technology EV-to-EBIT Related Terms
Tactile Systems Technology EV-to-EBIT Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Tactile Systems Technology's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Tactile Systems Technology EV-to-EBIT vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Tactile Systems Technology's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Tactile Systems Technology's EV-to-EBIT falls into.
Tactile Systems Technology's current Enterprise Value is $566.3 Mil.
Tactile Systems Technology's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $35.2 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Tactile Systems Technology (TCMD) has a EV-to-EBIT of 16.11 as of Jul. 22, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Tactile Systems Technology and its competitors. This is 25% below median its historical median of 21.41. According to the industry distribution chart, Tactile Systems Technology ranks #196 out of 465 companies in the Medical Devices & Instruments industry, placing it in the top 42.2%.
Is Tactile Systems Technology's EV-to-EBIT too high?
Tactile Systems Technology's current EV-to-EBIT of 16.11 is 25% below median its 10-year median of 21.41. The Medical Devices & Instruments industry median EV-to-EBIT is 18.28. Tactile Systems Technology's value of 16.11 is 11.9% below this industry median. Based on the distribution chart, Tactile Systems Technology ranks #196 out of 465 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Tactile Systems Technology has a GF Score™ of 74/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Tactile Systems Technology's EV-to-EBIT compare to SSII and BVS?
According to the Medical Devices & Instruments industry distribution chart, Tactile Systems Technology ranks #196 out of 465 companies for EV-to-EBIT. This puts Tactile Systems Technology in the upper half of its industry. The industry median EV-to-EBIT is 18.28. Tactile Systems Technology's value of 16.11 is 11.9% below this benchmark. While the company's 10-year median is 21.41 vs. the industry median of 18.28, Tactile Systems Technology has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Medical Devices & Instruments company?
The median EV-to-EBIT among Medical Devices & Instruments companies is 18.28, based on 465 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Tactile Systems Technology's current EV-to-EBIT of 16.11 is 11.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Tactile Systems Technology and its competitors. For the Medical Devices & Instruments industry, the median EV-to-EBIT is 18.28 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Tactile Systems Technology's current EV-to-EBIT is 16.11, which is 25% below median its own 10-year median of 21.41. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tactile Systems Technology stock overvalued right now?
Based on GuruFocus' analysis, Tactile Systems Technology (TCMD) is currently considered Significantly Overvalued. The stock's GF Value™ is $18.80, compared to a current price of $28.43 — trading 51.2% above its estimated fair value. The current EV-to-EBIT is 16.11, which is 25% below median its 10-year median of 21.41 and 11.9% below the Medical Devices & Instruments industry median of 18.28. Tactile Systems Technology's overall GF Score™ is 74/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Tactile Systems Technology (TCMD), the current EV-to-EBIT is 16.11 as of Jul. 22, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Tactile Systems Technology (TCMD) Overvalued in 2026?
Based on GuruFocus' analysis, Tactile Systems Technology stock appears to be overvalued.
The current stock price of $28.43 is trading 51.2% above its estimated GF Value™ of $18.80.
GuruFocus considers Tactile Systems Technology to be Significantly Overvalued.
Key valuation signals for TCMD:
EV-to-EBIT: 16.11 (25% below median its 10-year median of 21.41)
GF Value™: $18.80 vs. price of $28.43 (51.2% above fair value)
Industry Position: 11.9% below the Medical Devices & Instruments median (#196 of 465)
No single metric tells the full story. See the TCMD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Tactile Systems Technology Inc is a medical technology company. The company is engaged in developing and providing medical devices for the treatment of chronic diseases. The firm's proprietary platform flexitouch system, provides a home-based solution for lymphedema patients. The entire system is another home solution for patients with chronic swelling and actitouch system for chronic venous insufficiency patients that may be worn throughout the day.
74GF Score
Get the complete analysis for TCMD
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TCMD has been successfully added to your 
